rhinosinusitis


Also found in: Dictionary, Thesaurus, Encyclopedia.

rhi·no·si·nu·si·tis

(rī'nō-sī'nŭ-sī'tis),
Inflammation of the mucous membrane of the nose and paranasal sinuses.
Synonym(s): nasosinusitis

The American Academy of Otolaryngology and other authorities have recommended the use the of term rhinosinusitis instead of sinusitis because infection of the paranasal sinuses almost always occurs with, or as a complication of, viral rhinitis. Uncommonly, infection in a paranasal sinus without preceding viral upper respiratory infection can result from the prolonged presence of a nasogastric or endotracheal tube or nasal packing in a nostril or from dental infections or procedures. Some 16% of the U.S. population reports a diagnosis of sinusitis annually, and 16 million physician visits are made each year because of this condition. The mechanism whereby viral upper respiratory infection (URI) leads to rhinosinusitis includes obstruction of sinus ostia as a result of mucosal edema, stagnation of mucus due to increased mucus production, and impairment of ciliary activity caused by local inflammation, and faulty aeration of sinuses with resulting reduction in oxygen tension. Factors that are known or believed to increase the likelihood that rhinosinusitis will develop as a complication of acute viral URI include cigarette smoking; chronic allergic rhinitis, particularly with polyp formation; use of over-the-counter products containing first-generation antihistamines, which thwart the mucus transport system by drying nasal mucus and inhibiting ciliary action; abuse of decongestant nose drops or sprays, which can induce rebound nasal congestion, rhinitis medicamentosa, or both; and any anatomic abnormality that interferes with normal drainage and aeration of the sinuses. Septal deviation is the most widely recognized anatomic factor. Congenital narrowness of the middle meatus, into which the ostia of the frontal, maxillary, and anterior ethmoid sinuses drain, can predispose to sinus obstruction as a consequence of even slight nasal congestion. This condition has been called ostiomeatal complex. Most cases of acute rhinosinusitis are caused by viruses and are self-limited, resolving in 10-14 days with or without treatment. Although it is estimated that only 0.5%-2% of cases of acute rhinosinusitis are bacterial in origin, rhinosinusitis is the fifth most common condition for which antibiotics are prescribed, and the most common of all in ambulatory practice. One explanation for this lies in the inappropriate expectations and demands of a misinformed public. Nearly 50% of people surveyed believe that colds are caused by bacteria and can be cured with antibiotics. In addition, those with a history of recurrent rhinosinusitis often seek treatment early in the course of a common cold and are treated "expectantly" or "prophylactically" with antibiotics. Another reason for the widespread overuse of antibiotics to treat rhinosinusitis is that valid clinical diagnostic criteria to identify rhinosinusitis and to distinguish acute bacterial rhinosinusitis from viral infection are not available. Fever, green nasal discharge, a sense of pressure (not pain) in maxillary and frontal areas, and tenderness to palpation over these areas are all features of undifferentiated viral URI. Individual signs and symptoms that have been widely regarded by both physicians and laity as indicative of bacterial rhinosinusitis, such as maxillary pain, dental pain, purulent (white or off-white) nasal discharge, prolongation of nasal obstruction for more than 1 week, failure of obstruction to respond to oral decongestant, and biphasic illness (rhinitis beginning to improve and then relapsing) actually have little diagnostic value, although the occurrence of several of these together has a certain cumulative weight. Detection of purulent drainage from sinus ostia on rhinoscopy certainly suggests bacterial rhinosinusitis, but other diagnostic maneuvers are seldom useful in clinical practice; transillumination of the maxillary and frontal sinuses is of dubious value, imaging studies (plain x-rays and CT scan) are not cost effective, culture of nasal secretions reflects the mixed flora of the nose rather than pathogens within paranasal sinuses, and sinus puncture to obtain material for culture is painful. Acute bacterial rhinosinusitis is typically due to a single pathogen. The organisms most often cultured are Streptococcus pneumoniae, Haemophilus influenzae, Branhamella catarrhalis, Staphylococcus aureus, and anaerobes. Measures available for the treatment of rhinosinusitis are far from satisfactory. Oral decongestants and analgesics may help to allay symptoms. In selected cases, a brief course of a topical decongestant or oral corticosteroid may favorably affect the outcome. Nonsedating antihistamines, topical corticosteroids, or both are indicated when allergic rhinitis is a contributing factor. First-generation antihistamines, contained in many over-the-counter sinus and nighttime cold remedies, are contraindicated. Antibiotics favored for the treatment of acute bacterial rhinosinusitis are amoxicillin with or without clavulanate, trimethoprim-sulfamethoxazole, doxycycline, and various cephalosporins, macrolides, and fluoroquinolones. However, randomized clinical trials have failed to show that antibiotics consistently affect the course of acute rhinosinusitis, even when a bacterial cause has been demonstrated. More than 10% of the U.S. population suffers subacute (4-12 weeks) or chronic (longer than 12 weeks) rhinosinusitis each year. Physicians regularly prescribe antibiotic treatment for chronic rhinosinusitis, even though no study of the efficacy of such treatment in adults has been published in more than a generation, and placebo-controlled studies in children have failed to show any beneficial effect of antibiotics on either short-term or long-term outcome. Symptoms may be nonspecific, and allergic or vasomotor rhinitis may coexist with chronic bacterial infection. A surgical procedure to establish temporary or permanent artificial drainage of one or more sinus cavities is indicated for severe, intractable chronic rhinosinusitis and for disease complicated by extranasal spread of infection or by mucocele or pyocele. Grave complications of bacterial rhinosinusitis are orbital cellulitis, subperiosteal orbital abscess, osteomyelitis of the frontal bone (Pott puffy tumor), superior sagittal sinus thrombosis, and subdural, epidural, or intracerebral abscess.

rhinosinusitis

/rhi·no·si·nu·si·tis/ (ri″no-si″nŭ-si´tis) inflammation of the paranasal sinuses.

rhi·no·si·nu·si·tis

(rī'nō-sī'nŭs-ī'tis)
Inflammation of the mucous membrane of the nose and paranasal sinuses.

rhinosinusitis

Inflammation of the lining of the nose and of the sinuses surrounding the nose. This may be allergic as in ALLERGIC RHINITIS, infective, hormonal, occupational or emotional in origin.

rhinosinusitis

inflammation of the nasal cavity and sinuses.
References in periodicals archive ?
Nasal endoscopy in asthmatic children: Assessment of rhinosinusitis and adenoiditis incidence, correlations with cytology and microbiology.
ABRS may persist and become a chronic rhinosinusitis.
Is there any difference in the effect of therapeutic ultrasound and antibiotics (amoxicillin) on pain and congestion for acute bacterial rhinosinusitis in the short-term?
Antimicrobial treatment guidelines for acute bacterial rhinosinusitis.
We are delighted to be able to commercialize the unique, patented BDSI nanocochleate delivery technology using amphotericin B for the indication of chronic rhinosinusitis.
Patients must meet several criteria to be given a diagnosis of sinusitis or rhinosinusitis.
Rhinosinusitis Global Clinical Trials Review, H2, 2012 provides data on the Rhinosinusitis clinical trial scenario.
In fact, interleukin (IL)-5, eosinophil cationic protein, and IgE have all been found to differentiate chronic rhinosinusitis with nasal polyps from (1) chronic rhinosinusitis without nasal polyps and (2) cystic fibrosis with nasal polyps; both sensitivities and specificities were higher than 80%.
Chronic sinusitis or rhinosinusitis (CRS) affects around 11-15% of the general population[sup.
They address anatomy and embryology, physiology, advances in understanding the pathophysiology of rhinosinusitis, immunology, genetics, investigations, imaging, clinical examination and differential diagnosis, outcome measures and measurement tools, and conditions such as facial pain, disorders related to olfaction, rhinitis and rhinosinusitis, and trauma.
Rhinosinusitis initiative (RI) guidelines Major symptoms Minor symptoms Purulent nasal discharge Headache (anterior or posterior) Nasal obstruction/blockage Ear pain/pressure/fullness Facial congestion/fullness Halitosis Facial pain/pressure/fullness Dental pain Hyposmia/anosmia Cough Fever (acute only) Fever Fatigue (malaise) Table 3.
These evidence-based guidelines are similar in many respects to previously published guidelines, including the 2011 Canadian Clinical Practice Guidelines for Acute & Chronic Rhinosinusitis.